317 related articles for article (PubMed ID: 27390284)
1. Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis.
Selman M; López-Otín C; Pardo A
Eur Respir J; 2016 Aug; 48(2):538-52. PubMed ID: 27390284
[TBL] [Abstract][Full Text] [Related]
2. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
Pardo A; Selman M
Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
[TBL] [Abstract][Full Text] [Related]
3. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model.
Selman M; Pardo A
Am J Respir Crit Care Med; 2014 May; 189(10):1161-72. PubMed ID: 24641682
[TBL] [Abstract][Full Text] [Related]
4. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.
Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA
Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257
[TBL] [Abstract][Full Text] [Related]
5. FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro.
Joannes A; Brayer S; Besnard V; Marchal-Sommé J; Jaillet M; Mordant P; Mal H; Borie R; Crestani B; Mailleux AA
Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(7):L615-29. PubMed ID: 26773067
[TBL] [Abstract][Full Text] [Related]
6. The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis.
Selman M; Pardo A
Cell Signal; 2020 Feb; 66():109482. PubMed ID: 31760172
[TBL] [Abstract][Full Text] [Related]
7. Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis.
Kirillov V; Siler JT; Ramadass M; Ge L; Davis J; Grant G; Nathan SD; Jarai G; Trujillo G
Am J Pathol; 2015 Apr; 185(4):943-57. PubMed ID: 25660181
[TBL] [Abstract][Full Text] [Related]
8. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.
Wygrecka M; Kwapiszewska G; Jablonska E; von Gerlach S; Henneke I; Zakrzewicz D; Guenther A; Preissner KT; Markart P
Am J Respir Crit Care Med; 2011 Jun; 183(12):1703-14. PubMed ID: 21471103
[TBL] [Abstract][Full Text] [Related]
9. Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.
Newman DR; Sills WS; Hanrahan K; Ziegler A; Tidd KM; Cook E; Sannes PL
J Histochem Cytochem; 2016 Feb; 64(2):99-111. PubMed ID: 26538547
[TBL] [Abstract][Full Text] [Related]
10. The pathogenesis of idiopathic pulmonary fibrosis.
Coward WR; Saini G; Jenkins G
Ther Adv Respir Dis; 2010 Dec; 4(6):367-88. PubMed ID: 20952439
[TBL] [Abstract][Full Text] [Related]
11. Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis.
Froidure A; Marchal-Duval E; Homps-Legrand M; Ghanem M; Justet A; Crestani B; Mailleux A
Eur Respir Rev; 2020 Dec; 29(158):. PubMed ID: 33208483
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and dysregulated fibroblast proliferation--new mechanisms?
Kolb M
Sarcoidosis Vasc Diffuse Lung Dis; 2013 Sep; 30 Suppl 1():21-6. PubMed ID: 24081240
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic pulmonary fibrosis.
King TE; Pardo A; Selman M
Lancet; 2011 Dec; 378(9807):1949-61. PubMed ID: 21719092
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic pulmonary fibrosis: an altered fibroblast proliferation linked to cancer biology.
Vancheri C
Proc Am Thorac Soc; 2012 Jul; 9(3):153-7. PubMed ID: 22802290
[TBL] [Abstract][Full Text] [Related]
15. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
Wollin L; Wex E; Pautsch A; Schnapp G; Hostettler KE; Stowasser S; Kolb M
Eur Respir J; 2015 May; 45(5):1434-45. PubMed ID: 25745043
[TBL] [Abstract][Full Text] [Related]
16. Role of MicroRNAs in Signaling Pathways Associated with the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Focus on Epithelial-Mesenchymal Transition.
Cadena-Suárez AR; Hernández-Hernández HA; Alvarado-Vásquez N; Rangel-Escareño C; Sommer B; Negrete-García MC
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743055
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.
Korfei M; Skwarna S; Henneke I; MacKenzie B; Klymenko O; Saito S; Ruppert C; von der Beck D; Mahavadi P; Klepetko W; Bellusci S; Crestani B; Pullamsetti SS; Fink L; Seeger W; Krämer OH; Guenther A
Thorax; 2015 Nov; 70(11):1022-32. PubMed ID: 26359372
[TBL] [Abstract][Full Text] [Related]
18. The Interplay of the Genetic Architecture, Aging, and Environmental Factors in the Pathogenesis of Idiopathic Pulmonary Fibrosis.
Pardo A; Selman M
Am J Respir Cell Mol Biol; 2021 Feb; 64(2):163-172. PubMed ID: 32946290
[TBL] [Abstract][Full Text] [Related]
19. Epithelium-dependent profibrotic milieu in the pathogenesis of idiopathic pulmonary fibrosis: current status and future directions.
Xu X; Dai H; Wang C
Clin Respir J; 2016 Mar; 10(2):133-41. PubMed ID: 25047066
[TBL] [Abstract][Full Text] [Related]
20. Oxidative/nitrosative stress, autophagy and apoptosis as therapeutic targets of melatonin in idiopathic pulmonary fibrosis.
Hosseinzadeh A; Javad-Moosavi SA; Reiter RJ; Yarahmadi R; Ghaznavi H; Mehrzadi S
Expert Opin Ther Targets; 2018 Dec; 22(12):1049-1061. PubMed ID: 30445883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
